Healius eyes M&A after COVID-19 sales surge
Carrie LaFrenzSenior reporter
Updated
Key Points
- Revenue: ($m): 1900.7, up 22.1pc
- Pre-tax profit ($m): 167.8, up 167.2pc
- Net profit ($m): 43.7 from 70.5 loss
- Dividend (c): 6.8
Healius boss Malcolm Parmenter says the healthcare giant is seeking to make bolt-on purchases in its three key businesses – particular in the speciality areas of pathology.
Dr Parmenter told The Australian Financial Review that there was a pipeline of smaller deals in pathology, imaging, and day hospitals, but he warned that there was stiff competition at auctions.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles